NRG1 and Alzheimer disease: Although it is not clear yet how Aβ aggregation affects NRG1 expression in the AD brain, it is evident that NRG1 has therapeutic potential for AD by inducing neurogenesis, improving cognitive deficits, and restoring synaptic plasticity with [61] or without [63] affecting Aβ level.